105 related articles for article (PubMed ID: 2448889)
1. Modification of an amidolytic heparin assay to express protein-bound heparin and to correct for the effect of antithrombin III concentration.
Lyon SG; Lasser EC; Stein R
Thromb Haemost; 1987 Oct; 58(3):884-7. PubMed ID: 2448889
[TBL] [Abstract][Full Text] [Related]
2. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
Oshima G; Nagai T; Nagasawa K
Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins.
Young E; Cosmi B; Weitz J; Hirsh J
Thromb Haemost; 1993 Oct; 70(4):625-30. PubMed ID: 8115988
[TBL] [Abstract][Full Text] [Related]
4. Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.
ten Cate H; Lamping RJ; Henny CP; Prins A; ten Cate JW
Clin Chem; 1984 Jun; 30(6):860-4. PubMed ID: 6723041
[TBL] [Abstract][Full Text] [Related]
5. An improved heparin assay which is insensitive to platelet factor 4.
Fickenscher K; Buckler U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):873-8. PubMed ID: 2483705
[TBL] [Abstract][Full Text] [Related]
6. Development of a rapid and sensitive chromogenic heparin assay for clinical use.
Wagenvoord RJ; Hendrix HH; Kolde HJ; Hemker HC
Haemostasis; 1993; 23(1):26-37. PubMed ID: 8477906
[TBL] [Abstract][Full Text] [Related]
7. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
Drozd NN; Logvinova YS; Torlopov MA; Udoratina EV
Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptide substrates in hemostatic testing.
Fareed J; Messmore HL; Walenga JM; Bermes EW
Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
[TBL] [Abstract][Full Text] [Related]
9. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation.
Ireland HA; Boisclair MD; Lane DA; Thompson E; Curtis JR
Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095
[TBL] [Abstract][Full Text] [Related]
10. Standard assays underestimate the concentration of heparin in neonatal plasma.
Schmidt B; Mitchell L; Ofosu F; Andrew M
J Lab Clin Med; 1988 Nov; 112(5):641-3. PubMed ID: 3183496
[TBL] [Abstract][Full Text] [Related]
11. Anti-Xa clotting activities in different hepatic-triglyceride lipase preparations from post-heparin plasma.
Schmidt M; Barrowcliffe TW; Gray E; Watton J; Harenberg J
Thromb Res; 1991 Sep; 63(5):503-8. PubMed ID: 1755003
[TBL] [Abstract][Full Text] [Related]
12. [A method of determining heparin in blood plasma based on its antithrombin activity].
Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
[TBL] [Abstract][Full Text] [Related]
13. Heparin assay: a comparison between titrimetric and amidolytic methods.
Nenci GG; Berrettini M; Agnelli G; Parise P
Boll Soc Ital Biol Sper; 1980 Mar; 56(5):519-25. PubMed ID: 7387799
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of an automated assay of effective heparin activity in plasma.
Pierson-Perry JF; Obzansky DM; Mizzer JP
Clin Chem; 1987 Sep; 33(9):1630-4. PubMed ID: 3621562
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antithrombin III assays using biological and chromogenic substrates.
Philo RD; Gaffney PJ
Br J Haematol; 1982 Jan; 50(1):147-56. PubMed ID: 7055531
[TBL] [Abstract][Full Text] [Related]
16. [Automatization of heparin determination using chronometric evaluation of anti-Xa activity of the AT III-heparin complex].
Sampol J; Rossi JM; Lejay G
Ann Biol Clin (Paris); 1984; 42(1):21-3. PubMed ID: 6731952
[TBL] [Abstract][Full Text] [Related]
17. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
[TBL] [Abstract][Full Text] [Related]
18. [Determination of activity of antithrombin III - heparin in blood].
Katsadze IuL; Kotovshchikova MA
Lab Delo; 1982; (4):232-4. PubMed ID: 6177911
[No Abstract] [Full Text] [Related]
19. A rational approach to heparins.
Hemker HC; Béguin S
Nouv Rev Fr Hematol (1978); 1992; 34(1):5-9. PubMed ID: 1326098
[TBL] [Abstract][Full Text] [Related]
20. Anti-Xa activity of human hepatic triglyceride lipase.
Gray E; Bengtsson-Olivecrona G; Olivecrona T; Barrowcliffe TW
J Lab Clin Med; 1987 Jun; 109(6):653-9. PubMed ID: 3585139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
